↑ 疾患リストへ ← 戻る

 135. アイカルディ症候群 [臨床試験数:1,薬物数:9(DrugBank:3),標的遺伝子数:0,標的パスウェイ数:0] 

Searched query = "Aicardi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"    Synonyms (DrugBank) were also searched for.
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-002710-23-FR29 January 2018N/AN/A - AGSMedDRA version: 18.0 Level: PT Classification code 10054935 Term: Aicardi's syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]Trade Name: Zidovudine
Product Name: Zidovudine
Product Code: J05A F01
Pharmaceutical Form: Oral solution
INN or Proposed INN: Zidovudine
Other descriptive name: retrovir
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 100-
Trade Name: lamivudine
Product Name: lamivudine
Product Code: GX CJ7
Pharmaceutical Form: Oral solution
INN or Proposed INN: lamivudine
Other descriptive name: epivir
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 10-
Trade Name: Abacavir
Product Name: Abacavir
Product Code: GX 623
Pharmaceutical Form: Oral drops, solution
INN or Proposed INN: abacavir
Other descriptive name: ziagen
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 20-
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)Not RecruitingFemale: yes
Male: yes
24Phase 2France